Clinical trial
Antioxidant Supplementation in Patients With Kashin-Beck Disease
NCT00376025 · Innovative Humanitarian Solutions, Other · Unknown status
Key facts
| NCT number | NCT00376025 |
|---|---|
| Title | Antioxidant Supplementation in Patients With Kashin-Beck Disease |
| Official title | Study of the Effects of Antioxidant Supplementation in Patients Suffering From Kashin-Beck Disease |
| Lead sponsor | Innovative Humanitarian Solutions, Other |
| Collaborators | University of Houston - Victoria |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Kashin-Beck Disease |
| Intervention type | Dietary Supplement |
| Interventions | Biological Antioxidant Supplementation |
| Enrollment | 300 |
| Start date | Jul 1, 2007 |
| Primary completion | Jan 1, 2009 |
| Completion | Apr 1, 2009 |
| First posted | Sep 14, 2006 |
| Last update posted | Feb 22, 2008 |
| Countries | China |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: